ACT-HBV® : Advancing the Clinical Treatment of Hepatitis B Virus
Home CME Center Clinical Trials About ACT-HBV® Treatment Algorithms and Guidelines Ask the Experts
About ACT-HBV
Share this site with your colleagues! The E-mail addresses supplied will only be used to send information about ACT-HBV.com and will not be stored for future use in any way.
(* indicates required fields)
 
* Your Name: * Colleague's Name:
 
* Your E-mail Address: * Colleague's E-mail Address:
 
Message:
Submit
 
 
Online ResourcesContact Us Refer a Colleague Send Me Updates Legal Disclaimer
  
   
 
MDGUniversity of Wisconsin Medical School
The ACT-HBV Initiative in the United States is supported by independent educational grants from Bristol-Myers Squibb Company and Gilead Sciences. The ACT-HBV Initiative in the Asia-Pacific Region is supported by independent educational grants from Bristol-Myers Squibb Company and Novartis Pharma AG.